Association study of VEGFA polymorphisms in 180 advanced breast cancer patients treated with paclitaxel alone or paclitaxel plus bevacizumab and 183 untreated patients revealed that VEGFA-2578 AA genotype was associated with better median OS in the combination arm when compared with AC combined with CC genotype. Here, VEGFA is linked to breast carcinoma.